Stockscreener 앱 받기
9.85
3.34%
-0.34
시간 외 거래:
10.07
0.22
+2.23%
전일 마감가:
$10.19
열려 있는:
$10.16
하루 거래량:
2.42M
Relative Volume:
1.98
시가총액:
$749.47M
수익:
$11.40B
순이익/손실:
$-95.73M
주가수익비율:
-4.0204
EPS:
-2.45
순현금흐름:
$-64.37M
1주 성능:
+1.03%
1개월 성능:
+0.92%
6개월 성능:
+45.93%
1년 성능:
+63.62%
1일 변동 폭
$9.795
$11.02
1주일 범위
$9.11
$11.02
52주 변동 폭
$4.70
$11.02
Mind Medicine Inc Stock (MNMD) Company Profile
명칭
Mind Medicine Inc
전화
212-220-6633
주소
ONE WORLD TRADE CENTER, NEW YORK
MNMD을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
MNMD
Mind Medicine Inc
|
9.85 | 741.86M | 11.40B | -95.73M | -64.37M | -2.45 |
|
VRTX
Vertex Pharmaceuticals Inc
|
388.94 | 99.96B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
572.38 | 60.83B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
443.64 | 59.89B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
677.32 | 40.47B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
308.63 | 37.96B | 3.81B | -644.79M | -669.77M | -6.24 |
Mind Medicine Inc Stock (MNMD) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-08-04 | 재개 | Oppenheimer | Outperform |
| 2025-01-28 | 개시 | Evercore ISI | Outperform |
| 2024-12-20 | 개시 | Chardan Capital Markets | Buy |
| 2024-10-14 | 재개 | Leerink Partners | Outperform |
| 2024-07-24 | 개시 | ROTH MKM | Buy |
| 2024-05-29 | 개시 | Robert W. Baird | Outperform |
| 2024-04-15 | 개시 | Leerink Partners | Outperform |
| 2023-12-05 | 개시 | Canaccord Genuity | Buy |
| 2022-12-09 | 재개 | ROTH Capital | Buy |
| 2022-11-16 | 개시 | RBC Capital Mkts | Outperform |
| 2022-08-26 | 개시 | Oppenheimer | Outperform |
| 2022-08-10 | 개시 | Cantor Fitzgerald | Overweight |
| 2022-05-04 | 개시 | ROTH Capital | Buy |
| 2021-06-28 | 개시 | Maxim Group | Buy |
모두보기
Mind Medicine Inc 주식(MNMD)의 최신 뉴스
H.C. Wainwright Reiterates Buy Rating for Mind Medicine with $55 Price Target - AInvest
Enveric Biosciences: Poised to Outshine Traditional Psychedelic Targets - microdose.buzz
Is Mind Medicine (MindMed) Inc. Forming a Consolidation BaseTreasury Yields & Breakout Confirmation Trade Signals - newsimpact.co.kr
Mind Medicine (MindMed) Inc. Facing Inflection Point in Trend Analysis2025 Valuation Update & Momentum Based Trading Signals - 선데이타임즈
Mind Medicine (MindMed) Inc. Crosses 200 Day MA — Signal or NoiseWeekly Gains Summary & Detailed Earnings Play Alerts - 선데이타임즈
RSI Crosses Above 30 for Mind Medicine (MindMed) Inc. — Reversal in SightJuly 2025 News Drivers & Weekly Breakout Watchlists - 선데이타임즈
1 Reason to Buy MindMed (MNMD) - AOL.com
If You'd Invested $1,000 in Mind Medicine (MNMD) Stock 5 Years Ago, Here's How Much You'd Have Today - MSN
MindMed Announces New Employee Inducement Grants - Business Wire
MindMed (MNMD) Q2 2025 Earnings Call Transcript - AOL.com
MindMed Reports Strong Q2 2025 Results - The Motley Fool
Mind Medicine (MindMed) Inc.'s (NASDAQ:MNMD) large institutional owners must be happy as stock continues to impress, up 17% over the past week - simplywall.st
Mind Medicine (MindMed) (NASDAQ:MNMD) Earns Outperform Rating from Analysts at Oppenheimer - MarketBeat
Using RSI to spot recovery in Mind Medicine (MindMed) Inc.Weekly Breakout Forecast with Entry Zones - Newser
What makes Mind Medicine (MindMed) Inc. stock price move sharplyFree Trade Ready Stock Watch for Short Term - Newser
MindMed Reports Strong Phase 3 Trial Progress and Leadership Appointment - The Globe and Mail
Pattern recognition hints at Mind Medicine (MindMed) Inc. upsideAlpha Generation Strategy with Low Volatility - Newser
Roth Capital Issues Pessimistic Outlook for MNMD Earnings - Defense World
What MACD signals say about Mind Medicine (MindMed) Inc.AI-Based Reversal Point Prediction Signal - Newser
What is HC Wainwright’s Forecast for MNMD FY2028 Earnings? - Defense World
Oppenheimer Initiates Coverage on Mind Medicine (MindMed) (NASDAQ:MNMD) - Defense World
Is Mind Medicine stock a buy? - Cantech Letter
Mind Medicine upgraded at Oppenheimer on lead asset - MSN
A Quick Look at Today's Ratings for Mind Medicine(MNMD.US), With a Forecast Between $18 to $55 - 富途牛牛
Analysts Are Bullish on Top Healthcare Stocks: Mind Medicine (MNMD), Axsome Therapeutics (AXSM) - The Globe and Mail
MindMed Bets Big On Psychedelic Therapies With Cash To Spare - Finimize
Mind Medicine stock upgraded at Oppenheimer (MNMD:NASDAQ) - Seeking Alpha
Mind Medicine's Promising Pipeline and Financial Stability Drive Buy Rating - AInvest
Mind Medicine resumed with an Outperform at Oppenheimer - TipRanks
Mind Medicine’s Promising Pipeline and Financial Stability Drive Buy Rating - TipRanks
Mind Medicine (MNMD) Gains Positive Outlook with Oppenheimer's O - GuruFocus
Mind Medicine (MindMed)’s (MNMD) “Buy” Rating Reiterated at Chardan Capital - Defense World
What are the latest earnings results for Mind Medicine (MindMed) Inc.Invest confidently with advanced analysis tools - Jammu Links News
Why is Mind Medicine (MindMed) Inc. stock attracting strong analyst attentionFree Trading Psychology Coaching - Jammu Links News
How does Mind Medicine (MindMed) Inc. compare to its industry peersGet timely alerts on market opportunities - Jammu Links News
What is the dividend policy of Mind Medicine (MindMed) Inc. stockOutstanding capital returns - Jammu Links News
What analysts say about Mind Medicine (MindMed) Inc. stockAccelerate your capital gains today - Jammu Links News
Is it the right time to buy Mind Medicine (MindMed) Inc. stockHigh-yield portfolio picks - Jammu Links News
How does Mind Medicine (MindMed) Inc. generate profit in a changing economyAchieve rapid financial growth with smart picks - Jammu Links News
When is Mind Medicine (MindMed) Inc. stock expected to show significant growthAchieve breakthrough investment performance - Jammu Links News
How volatile is Mind Medicine (MindMed) Inc. stock compared to the marketAI Powered Signals For Consistent Profits - jammulinksnews.com
MindMed (MNMD) Q2 Net Loss Jumps 625% - The Globe and Mail
MindMed Reports Strong Q2 2025 Financial Results - The Globe and Mail
Unraveling the Sharp Drop in Mind Medicine (MNMD.O): A Technical and Order-Flow Deep Dive - AInvest
Mind Medicine Inc's Q2 2025 Earnings Call Highlights: Strong Financial Position and Strategic Advancements in MM-120 ODT Trials - AInvest
Earnings call transcript: MindMed Q2 2025 reveals cash runway into 2027 - Investing.com Canada
Mind Medicine (MindMed) Q2 2025 Earnings Call Transcript - MarketBeat
Mind Medicine Inc (MNMD) 재무 분석
매출
순이익
현금흐름
주당 순 이익
Mind Medicine Inc 주식 (MNMD) 내부자 거래
| 내부자 거래 | 관계 | 날짜 | 거래 | 비용 | #주식 | 가치 ($) | #주식 총계 |
|---|---|---|---|---|---|---|---|
| Karlin Daniel | Chief Medical Officer |
Jun 25 '25 |
Sale |
6.80 |
7,848 |
53,366 |
438,329 |
| Barrow Robert | Chief Executive Officer |
Jun 25 '25 |
Sale |
6.80 |
26,491 |
180,139 |
830,065 |
1.38%
0.27%
자본화:
|
볼륨(24시간):